JG
CCCC icon

Jain Global’s C4 Therapeutics CCCC Stock Holding History

Jain Global’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$164K Buy
62,390
+49,628
+389% +$117K ﹤0.01% 1105
2025
Q4 		$24.4K Buy
+12,762
New +$30.2K ﹤0.01% 1181
2025
Q3 		– Sell
-136,219
Closed -$195K – 1076
2025
Q2 		$195K Buy
136,219
+112,016
+463% +$163K ﹤0.01% 981
2025
Q1 		$38.7K Buy
+24,203
New +$72.2K ﹤0.01% 1021

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jain Global's CCCC Position: Q1 2026 in Review

Jain Global increased its C4 Therapeutics (CCCC) stake by 389% in Q1 2026, buying an estimated $117K and bringing the position to 62,390 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #1105.

Jain Global first reported a position in CCCC in Q1 2025 and has held it in 4 quarters since. The position peaked at $195K in Q2 2025. 123 funds tracked by Wall St. Rank hold CCCC as of Q1 2026.

  • Jain Global held 62,390 shares of C4 Therapeutics worth $164K as of Q1 2026.
  • Jain Global bought 49,628 C4 Therapeutics shares in Q1 2026, an estimated $117K.
  • C4 Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q1 2026, its #1105 holding.
  • Jain Global first reported a position in C4 Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Jain Global's C4 Therapeutics position peaked at $195K in Q2 2025.
  • 123 funds tracked by Wall St. Rank held C4 Therapeutics as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.